Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, and Myeloproliferative Neoplasms: Diagnosis and Treatment.
Treatment of Pleural Mesothelioma: ASCO Guideline Update
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults
Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma
ANKRD26-related thrombocytopenia: Hematologic malignancy characteristics, clinical outcomes, and precursor states
The MEASURE Genome Atlas: Acute Myeloid Leukemia at diagnosis and complete remission
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in <i>RUNX1</i>, <i>GATA2</i>, and <i>DDX41</i>
Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages
Clonal hematopoiesis in patients with <i>ANKRD26</i> or <i>ETV6</i> germline mutations
Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in <i>RUNX1</i>, <i>GATA2</i> and <i>DDX41</i>
The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy
Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology
Germline predisposition to hematopoietic malignancies
Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model
Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies
Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes
Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
Genetic predisposition to leukemia and other hematologic malignancies
Analysis of Impact of Post-Treatment Biopsies in Phase I Clinical Trials